Abstract
Malaria is among the most common preventable causes of adverse pregnancy outcomes. WHO recommends intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine for HIV-negative women; however, parasite resistance now threatens the effectiveness of this approach.
| Original language | English |
|---|---|
| Pages (from-to) | 1051-1052 |
| Number of pages | 2 |
| Journal | The Lancet Infectious Diseases |
| Volume | 18 |
| Issue number | 10 |
| Early online date | 5 Sept 2018 |
| DOIs |
|
| Publication status | Published - 1 Oct 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Back to chloroquine for malaria prophylaxis in pregnancy?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver